Allison Proffitt - Profile and Journalist Details

Find journalists that align with your industry, location and vision. Unlock Allison Proffitt's full journalist profile, including location, coverage topics, current employer, biography and preferences. Sign up today and start building journalist relationships that fuel your startup's growth.

Get connected with journalists today
Allison Proffitt

Allison Proffitt

Verified

Editorial Director, Bio-IT World

Nashville

Final Covers

Local Municipal And Sports News , Autism , Disability Issues

Doesn’t Cover

Parenting/kids, pets, DIY

Journalist Type

Seniority Positions

Industries

Medium Formats

Content

Total articles 913

  • Insilico’s Alex Zhavoronkov Highlights Generative AI's Impact on Drug Discovery and Aging Research

    By Allison Proffitt Verified| Bio-IT World Verified By Allison Proffitt April 17, 2025 | At the Bio-IT World Conference & Expo earlier this month, Alex Zhavoronkov, CEO and founder of Insilico Medicine, shared the company's progress in leveraging generative AI to accelerate drug discovery, particularly focusing on aging research. Celebrating the company's 11th year, Zhavoronkov emphasized his singular mission: helping people live longer, healthier lives. "Currently, my problem in life is that there are so many ways to diagnose aging.

    By Allison Proffitt Verified · Bio-IT World

    Apr. 16, 2025

  • Derek Lowe on AI in Drug Discovery: Between Hype and Hope

    By Allison Proffitt Verified| Bio-IT World Verified By Allison Proffitt April 15, 2025 | At last week’s Venture, Innovation, and Partnering Summit at the Bio-IT World Conference & Expo, Derek Lowe, Director, Chemical Biology & Therapeutics at Novartis BioMedical Research, and John Keilty, venture partner at Third Rock Ventures, sat down for a candid conversation on the pharmaceutical industry and the current state of artificial intelligence and machine learning (AI/ML) in drug discovery.

    By Allison Proffitt Verified · Bio-IT World

    Apr. 14, 2025

  • Insilico’s Alex Zhavoronkov Highlights Generative AI's Impact on Drug Discovery and Aging Research

    By Allison Proffitt Verified| Bio-IT World Verified By Allison Proffitt April 17, 2025 | At the Bio-IT World Conference & Expo earlier this month, Alex Zhavoronkov, CEO and founder of Insilico Medicine, shared the company's progress in leveraging generative AI to accelerate drug discovery, particularly focusing on aging research. Celebrating the company's 11th year, Zhavoronkov emphasized his singular mission: helping people live longer, healthier lives. "Currently, my problem in life is that there are so many ways to diagnose aging.

    By Allison Proffitt Verified · Bio-IT World

    Apr. 16, 2025

As seen in

Company Info

Bio-IT World

Bio-IT World Expo is a company based out of MA, United States.

'+1 781-972-5400